Cite
HARVARD Citation
Dunlap, J. et al. (n.d.). The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML. American journal of hematology. 94 (8), pp. 913-920. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dunlap, J. et al. (n.d.). The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML. American journal of hematology. 94 (8), pp. 913-920. [Online].